Rd. Schoenwald et al., PENETRATION INTO THE ANTERIOR-CHAMBER VIA THE CONJUNCTIVAL SCLERAL PATHWAY/, Journal of ocular pharmacology and therapeutics, 13(1), 1997, pp. 41-59
The importance of the conjunctival/scleral pathway as a route of entry
into the ciliary body, and in particular uptake and depostion by vess
els, was investigated. A constant concentration of methazolamide analo
gs as well as 6-carboxyfluorescein (6-CB) and rhodamine B (RE) was mai
ntained on either the cornea or the conjunctiva/sclera tissue, the lat
ter excluding the cornea. The solutions were applied with the use of a
cylindrical well affixed to the cornea of an anesthetized white rabbi
t. After two hours, concentrations of drug or dye were measured in cor
nea, aqueous humor or iris/ciliary body for both routes of entry. Conf
ocal microscopy methods were used to determine reflected fluorescence
images for 6-CB and RE. Carbonic anhydrase inhibition, partitioning, s
olubility and intraocular pressure (IOP) measurements were also determ
ined. Permeability calculations were estimated for drug diffusing agai
nst aqueous now within the posterior chamber. The conjunctival/scleral
route of entry produced higher iris/ciliary body concentrations for a
ll compounds except for the lipophilic RE. Confocal microscopy results
suggested that drug is gaining entry into the ciliary body through ve
ssel uptake in the sclera. Following entry of drug into the conjunctiv
al/scleral tissue, a significant portion enters scleral vessels and de
posits within the ciliary body. Calculations are given that indicate t
hat once drug penetrates the cornea it is highly unlikely drug diffuse
s through the pupil against aqueous flow to enter the posterior chambe
r and reach the ciliary body.